Annual Cash & Cash Equivalents
$147.12 M
-$42.60 M-22.46%
December 31, 2022
Summary
- As of February 10, 2025, CYT annual cash & cash equivalents is $147.12 million, with the most recent change of -$42.60 million (-22.46%) on December 31, 2022.
- During the last 3 years, CYT annual cash & cash equivalents has risen by +$118.11 million (+407.10%).
Performance
CYT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$129.24 M
-$4.39 M-3.29%
September 30, 2023
Summary
- As of February 10, 2025, CYT quarterly cash and cash equivalents is $129.24 million, with the most recent change of -$4.39 million (-3.29%) on September 30, 2023.
- Over the past year, CYT quarterly cash and cash equivalents has dropped by -$24.65 million (-16.02%).
Performance
CYT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CYT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.5% | -16.0% |
| 3 y3 years | +407.1% | - |
| 5 y5 years | +407.1% | - |
CYT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.5% | at low | -31.9% | at low |
| 5 y | 5-year | -22.5% | -92.6% | -35.3% | -91.5% |
| alltime | all time | -22.5% | -92.6% | -35.3% | -91.5% |
Cyteir Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $129.24 M(-3.3%) |
| Jun 2023 | - | $133.63 M(-2.6%) |
| Mar 2023 | - | $137.20 M(-6.7%) |
| Dec 2022 | $147.12 M | $147.12 M(-4.4%) |
| Sep 2022 | - | $153.89 M(-7.5%) |
| Jun 2022 | - | $166.40 M(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $177.38 M(-6.5%) |
| Dec 2021 | $189.72 M(+1634.5%) | $189.72 M(-5.1%) |
| Sep 2021 | - | $199.82 M(+0.6%) |
| Jun 2021 | - | $198.64 M(+135.9%) |
| Mar 2021 | - | $84.19 M(+669.7%) |
| Dec 2020 | $10.94 M(-62.3%) | $10.94 M |
| Dec 2019 | $29.01 M | - |
FAQ
- What is Cyteir Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cyteir Therapeutics?
- What is Cyteir Therapeutics annual cash & cash equivalents year-on-year change?
- What is Cyteir Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cyteir Therapeutics?
- What is Cyteir Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Cyteir Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CYT is $147.12 M
What is the all time high annual cash & cash equivalents for Cyteir Therapeutics?
Cyteir Therapeutics all-time high annual cash & cash equivalents is $189.72 M
What is Cyteir Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CYT annual cash & cash equivalents has changed by -$42.60 M (-22.46%)
What is Cyteir Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CYT is $129.24 M
What is the all time high quarterly cash and cash equivalents for Cyteir Therapeutics?
Cyteir Therapeutics all-time high quarterly cash and cash equivalents is $199.82 M
What is Cyteir Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CYT quarterly cash and cash equivalents has changed by -$24.65 M (-16.02%)